Diplomat, a publicly traded company under NYSE ticker symbol DPLO, is a leading provider of medication management programs for patients with complex chronic diseases across the United States. Based in Flint, Michigan, the company caters to a range of serious or long-term conditions such as oncology, immunology, hepatitis, multiple sclerosis, infusion therapy, and more. With a commitment to supporting patients and physicians alike, Diplomat serves as a crucial player in the healthcare industry.